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Background-—Atrial fibrillation (AF), often associated with structural, fibrotic change in cardiac tissues involving regulatory
signaling mediators, becomes increasingly common with age. In the present study, we explored the role of mitogen-activated
protein kinase kinase 4 (Mkk4), a critical component of the stress-activated mitogen-activated protein kinase family, in age-
associated AF.
Methods and Results-—We developed a novel mouse model with a selective inactivation of atrial cardiomyocyte Mkk4 (Mkk4ACKO).
We characterized and compared electrophysiological, histological, and molecular features of young (3- to 4-month), adult
(6-month), and old (1-year) Mkk4ACKO mice with age-matched control littermates (Mkk4F/F). Aging Mkk4ACKO mice were more
susceptible to atrial tachyarrhythmias than the corresponding Mkk4F/F mice, showing characteristic slow and dispersed atrial
conduction, for which modeling studies demonstrated potential arrhythmic effects. These differences paralleled increased
interstitial fibrosis, upregulated transforming growth factor beta 1 (TGF-b1) signaling and dysregulation of matrix metalloprotein-
ases in Mkk4ACKO, compared to Mkk4F/F, atria. Mkk4 inactivation increased the sensitivity of cultured cardiomyocytes to
angiotensin II–induced activation of TGF-b1 signaling. This, in turn, enhanced expression of profibrotic molecules in cultured
cardiac fibroblasts, suggesting cross-talk between these two cell types in profibrotic signaling. Finally, human atrial tissues in AF
showed a Mkk4 downregulation associated with increased production of profibrotic molecules, compared to findings in tissue from
control subjects in sinus rhythm.
Conclusions-—These findings together demonstrate, for the first time, that Mkk4 is a negative regulator of the TGF-b1 signaling
associated with atrial remodeling and arrhythmogenesis with age, establishing Mkk4 as a new potential therapeutic target for
treating AF. ( J Am Heart Assoc. 2014;3:e000340 doi: 10.1161/JAHA.113.000340)
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A trial fibrillation (AF) is the most common chronic cardiacarrhythmia. It contributes significantly to population
morbidity and mortality with a prevalence increasing with age,
affecting 5% of the population over 65 years. It is widely
recognized that development of atrial fibrosis leading to
remodeling contributes to persistence of AF in human
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subjects. The genes and signaling pathways modulating this
development are thus potential novel therapeutic targets, but
identification of their relevant key signaling mediators would
be critical to this end.
Mitogen-activated protein kinases (MAPKs) are a group of
serine/threonine kinases that play a central role in cellular
responses to diverse stimuli, including environmental stress,
proinflammatory cytokines, and developmental cues. Their
cardiac roles have become a focus of recent research through
their involvement in the pathogenesis of cardiac hypertrophy
and cardiac failure.1 They have also been implicated in the
pathogenesis of AF, through their mediation of angiotensin II
(Ang II) action.2,3 Ang II type 1 receptor activation is known to
induce a cascade of phosphorylations that activate MAPKs,
which, in turn, stimulates fibroblast proliferation, cellular
hypertrophy, and apoptosis.4–6 Tachypacing in canine hearts
increases atrial Ang II production and expression of extracel-
lular signal-regulated kinase (ERK), c-Jun N-terminal kinase
(JNK), and p38-kinase. This was accompanied by substantial
changes in their phosphorylated forms. Such findings impli-
cate MAPK activation in arrhythmogenic atrial structural
remodeling. However, Ventura et al.7 recently demonstrated
that JNK regulated transforming growth factor beta 1 (TGF-
b1)-mediated biological responses by suppressing TGF-b1
gene expression, indicating a negative regulatory role in TGF-
b1 signaling. Moreover, attenuation of cardiac p38 activity
produced a progressive growth response and myopathy in the
heart that correlated with the degree of enzymatic inhibition.
Furthermore, dominant-negative p38a, mitogen-activated pro-
tein kinase kinase (Mkk)3, and Mkk6 transgenic mice all
showed enhanced cardiac hypertrophy after aortic banding,
Ang II infusion, isoproterenol infusion, or phenylephrine
infusion for 14 days.8 These apparent discrepancies reflect
the complexity of the MAPK cascades in the heart, highlight-
ing the need for further study of their role and the related
signal transduction processes in cardiac tissues.
MKK4 is a critical member of the MAPK family. Its
function is associated with JNK signaling through its action
as the upstream kinase of JNK. MKK4 and its closely related
family member, MKK7, preferentially phosphorylate JNK on
its threonine 183 and tyrosine 185 residues, respec-
tively.9,10 In contrast to MKK7, MKK4 was also reported
additionally to activate p38 in some cell types.11,12 Targeted
deletion of either the Mkk4 or Mkk7 gene leads to
embryonic lethality, providing genetic evidence that Mkk4
and Mkk7 have nonredundant roles in vivo.13 These data
indicate a central role for MKK4 in the JNK signal
transduction pathway. Furthermore, recent studies, including
ours, have provided strong evidence demonstrating the
functional importance of MKK4 in the heart, where it is
required for protecting the heart from maladaptive
pathological hypertrophy through activation of the JNK
pathway.14,15 We further demonstrated that MKK4 pre-
vented stress-associated ventricular arrhythmias through
regulation of connexin 43 (Cx43) expression.15
Despite the biological importance of MKK4 being demon-
strated in the ventricles, its role in the atrium has not been
previously explored. The present study developed a condi-
tional knockout mouse model with an atrial cardiomyocyte-
selective deletion of Mkk4 using the natriuretic peptide
precursor A (Nppa) promoter-driven Cre transgene16 by using
the Cre-LoxP system. It then investigated the effects of Mkk4
deletion on atrial electrophysiological and structural proper-
ties with age.
Methods
Animal Models
Generation of Mkk4ACKO mice
Mkk4 was specifically deleted from the atria of the heart using
the Cre-LoxP system. Mkk4 flox/flox (Mkk4F/F) mice14 were
crossed with Nppa-Cre4 mice, which express CRE only in
atrial cardiomyocytes,16 to generate atrial-specific Mkk4
knockout mice (Mkk4ACKO). The Nppa-Cre4 line (kindly
provided by Dr. V.M. Christoffels) is a well-established model
that provides efficient atrial-specific Cre recombinase activity,
without causing any abnormality in cardiac morphology or
function. Young adult mice in this study were 3 months of
age, whereas old mice were 12 months of age. All mice used
in this study were maintained in a pathogen-free facility at the
University of Manchester (Manchester, UK). Animal studies
were performed in accord with the UK Home Office and
institutional guidelines. The procedures followed were in
accord with institutional guidelines.
Neonatal rat cardiomyocytes (NRCMs) were isolated from
1- to 2-day-old Sprague-Dawley rats using the standard
enzymatic method described previously.17 Using the same
protocol as for NRCMs, neonatal rat cardiac fibroblasts
(NRCFs) were prepared from hearts of 1- to 2-day-old
Sprague-Dawley rats. NRCMs were infected with adenovirus
encoding green fluorescent protein (Ad-GFP), as a control or
dominant negative MKK4 adenovirus (Ad-dnMKK4; Seven Hills
Bioreagents, Cincinnati, OH) at 25 multiplicities of infection in
serum-free medium, 48 hours after plating of the cells.
Twenty-four hours after infection, the virus was removed.
After adenovirus infection and removal, NRCMs were treated
with Ang II (500 nmol/L) for 24 hours and RNA was extracted
using the Qiagen RNeasy Minikit (Qiagen, T€ubingen, Ger-
many), following the manufacturer’s guidelines. To assess the
interplay between MKK4-inactivated cardiomyocytes and
fibroblasts, NRCM-conditioned media were then transferred
to plated cardiac fibroblasts that were then incubated for
24 hours before RNA was extracted. Real-time polymerase
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chain reaction (PCR) was carried out on target genes from
NRCMs and fibroblasts, as described below.
Human Tissue Samples
Right atrial appendages were dissected from 15 control
patients and 15 chronic AF patients (patients’ clinical
information is shown in Table 1). The study was approved
by an institutional review committee and subjects gave
informed consent. Thus, experimental protocols were
approved by the ethics committee of the Dresden University
of Technology (EK790799; Dresden, Germany). Each patient
gave written informed consent. After excision, atrial append-
ages were flash-frozen in liquid nitrogen for subsequent
biochemical studies.
Electrocardiography
Cardiac rhythms were assessed by in vivo ECG analysis on
isoflurane-anesthetized mice (2.5%) that measured RR inter-
vals, P wave durations, PR intervals, and QRS, JT, and QT
durations.
Programmed Electrical Stimulation
Propensity to atrial arrhythmias in Langendorff-perfused
hearts from 3- to 4- and 12-month-old mice was assessed
by programmed electrical stimulation (PES). Pacing trains of
eight stimuli (S1) delivered at a basic cycle length of 100 ms
were followed by a single (S2) premature extrastimuli
introduced at S1S2 intervals progressively shortened with
successive stimulus cycles repeated until arrhythmia was
induced or the atrial refractory period was reached. A burst-
pacing protocol applied atrial pacing in trains of 20 S1 stimuli
at progressively shorter intervals from an initial cycle length of
100 ms until an arrhythmia was induced or CL of 30 ms was
reached. Arrhythmia was defined as three or more consecu-
tive premature atrial waveforms. Tachycardia showing regular
waveforms was defined as AT, whereas irregular fibrillating
waveforms was considered to represent AF.
Epicardial Activation Mapping
Left and right atrial epicardial activation mapping in isolated
Langendorff-perfused hearts used a custom-made multielec-
trode array containing 32 electrodes in a 498 grid, with
interelectrode distances of 0.20 mm along the longitudinal
and 0.35 mm along the transverse axis (0.3 mm), paced at
a basic cycle length of 100 ms. Activation times were
determined as the point of maximal negative slope and
displayed in a grid representing the layout of the original
recording array. All activation times were related to the
timing of the first detected waveform. Isochrones were
drawn manually around areas activated in increments of
1 ms.
Mathematical Model of Mouse Atria
A computational model for the action potential (AP) of a single
mouse atrial cardiomyocyte was developed in this study. This
modified the previously published mouse ventricular model18
incorporating experimental data on ionic channel properties
of murine atrial cardiomyocytes. Equations for L-type Ca2+
Table 1. Clinical Features of Patients Studied
SR AF
Patient number, n 15 15
Gender, male/female 12/3 11/4
Age, y 69.51.9 69.32.0
Height, cm 1691 1722
Weight, kg 80.92.6 88.14.1
Body mass index, kg/m2 28.30.8 29.81.2
CAD, n 14 5*
MVD/AVD, n 10 14
CAD+MVD/AVD, n 10 4
Pulmonary hypertension, n 4 9
Hypertension, n 14 15
Diabetes, n 8 8
Hyperlipidemia, n 11 6
LVEF, % 52.02.8 47.33.9
LVEDD, mm 49.82.2 50.23.0
LVSTD, mm 13.50.7 13.30.5
LVWTD, mm 12.30.7 12.30.4
LADD, mm 42.21.6 51.61.2*
Digitalis, n 0 3
ACE inhibitors, n 10 9
AT1 blockers, n 2 3
b-Blockers, n 14 13
Ca2+-antagonists, n 3 3
Diuretics, n 9 12
Nitrates, n 0 1
Lipid-lowering drugs, n 13 7*
ACE indicates angiotensin-converting enzyme; AF, atrial fibrillation; AT, angiotensin
receptor; AVD, aortic valve disease requiring valve replacement; CAD, coronary artery
disease; LADD, left atrial diastolic diameter; LVEDD, left ventricular end diastolic
diameter; LVEF, left ventricular ejection fraction; LVSTD, left ventricular septum
thickness at diastole; LVWTD, left ventricular wall thickness at diastole; MVD, mitral
valve disease requiring valve replacement; SR, sinus rhythm.
*P<0.05 values from unpaired Student t test for continuous variables and from chi-
square test for categorical variables.
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currents (ICaL) used experimental data of Lomax et al.
19
Equations for the time- and voltage-dependent transient
outward (IKtof), ultrarapidly delayed rectifier (IKur) and nonin-
activating steady-state K+ currents (IKss) used experimental
data from Lomax et al.,19 Bou-Abboud et al.,20 and Nakamura
et al.21 Equations for the inward rectifier K+ current (IK1) used
experimental data from Panama et al.22 Equations for
remaining ion channel currents were the same as those used
in the mouse ventricular model18 because of the lack of atrial-
specific experimental data.
The model successfully reproduced the murine atrial AP
with its detailed characteristics of resting potential, AP
duration (APD) and amplitude, and upstroke velocity matching
experimental data and their rate dependence.19–22 The single-
cell model was then incorporated into a two-dimensional (2D)
tissue model with dimensions of 15920 mm, which was
discretized into a lattice of 1509200 nodes with a spatial
resolution of 0.1 mm. The membrane voltage (Vm) for a
cardiomyocyte in this tissue matrix was given by the following
equation:
@Vm
@t
¼ rDðx; yÞrVm þ Iion þ Istim
where D(x, y) simulates the gap junctional coupling, Iion is the
membrane current, and Istim is the stimulus current.
In order to investigate the effects of cardiomyocyte-
fibroblast coupling on the conduction velocity (CV) of atrial
excitation waves and assess its possible roles in causing of
re-entry, a fibroblast model23 was incorporated into the tissue
model. This defined a coupling between cardiomyocyte-
fibroblast by writing the following equation:
C
dV
dt
¼ Iion þ
Xn
i¼1
GigapðV i  VÞ:
C is the membrane capacitance of a given cardiomyocyte (Cm)
or a fibroblast (Cf), Iion is the corresponding membrane current
(Im or If), n is the number of coupled neighbors (either
cardiomyocytes or fibroblasts), and Gigap is the gap junctional
conductance between a cell (either a cardiomyocyte or a
fibroblast) and its neighbor. Cm and Cf were set to 153.4 pF
and 6.3 pF, respectively. Ggap was set to 3 nS.
In the 2D tissue model, the number of fibroblasts (ranging
from 1 to 5) was randomly distributed among cardiomyocytes,
with the overall fibroblast density scaled by the ratios of the
measured population of fibrosis from Mkk4ACKO and Mkk4F/F
and their related aging groups. They were either attached to
one cardiomyocyte (one-sided coupling) or interconnected
neighboring cells (end-to-end coupling; Figure 8A). The value
for D(x, y) was also chosen to simulate the measured
conduction velocity from Mkk4ACKO and Mkk4F/F and their
related aging groups in the control conditions.
Immunohistochemical Analyses
Atrial and ventricular tissue was frozen in optimal cutting
temperature and 10-lm sections were collected using a
cryostat. Sections were stained for fibrosis using the picros-
irius red stain and bright field images were taken at 109
magnification for quantification. For illustration purposes,
409 magnification images of representative areas were
taken. Fibrotic areas were quantified using ImageJ software
(National Institutes of Health, Bethesda, MD).
Quantitative Real-Time PCR
Total RNA was extracted from frozen tissue using an RNeasy
Mini Kit (Qiagen), and cDNA was synthesized using the
Superscript™ III First Strand Synthesis System (Invitrogen,
Carlsbad, CA) using oligo dT primers. Real-time PCR was
performed using SYBR green (Applied Biosystems, Foster City,
CA), and primers were obtained from Qiagen. PCR products
were detected in the ABI-PRISM 7700 sequence detection
system (Applied Biosystems), and the results were analyzed
using the 2DDCT method. The mRNA levels of each gene were
normalized to hypoxanthine phosphoribosyltransferase (HPRT)
levels.
Immunoblot Analysis
Protein extracts (50 lg) were subjected to immunoblot analysis
with antibodies (Abs) againstMkk4 (BD Pharmingen, SanDiego,
CA), ERK1/2 (Cell Signaling Technology, Danvers, MA), JNK
(Santa Cruz Biotechnology, Santa Cruz, CA), p38 (Santa Cruz
Biotechnology), and tubulin (Sigma-Aldrich, St. Louis, MO).
Immune complexes were detected by enhanced chemilumi-
nescence with anti-mouse, -rabbit, or -goat immunoglobulin G
coupled to horseradish peroxidise as the secondary Ab
(Amersham-Pharmacia Biotech Inc., Piscataway, NJ).
Luciferase Reporter Assay
After adenovirus infection and removal, NRCMs were treated
with Ang II (500 nmol/L) for 24 hours. NRCM-conditioned
media were then transferred to plated TMLC cells and left for
24 hours. TMLC cells are a TGF-b1 reporter cell line, with a
PAI-1 promoter luciferase construct stably transfected.24
TMLC cells were harvested and luciferase activity measured,
using a luciferase assay kit (Promega, Madison, WI) and
following the manufacturer’s guidelines.
Data Analysis
Data are presented as meansSEM, unless indicated
otherwise. Statistical analysis used SPSS Statistics 19
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software (SPSS, Inc., Chicago, IL) with P values <0.05
considered statistically significant. Before parametric statis-
tical analysis, the Shapiro-Wilk test was used to assess the
null hypothesis that data sets derived from a normally
distributed population where there was a probability P>0.05
would not result in rejection of the hypothesis that the data
came from a normally distributed population. Student t tests
were then used in comparisons where there were two groups,
with the paired-sample t test used for testing differences
between paired groups. Two-way ANOVA was used in
comparisons among multiple groups. These were then
followed by post-hoc, Bonferonni-corrected t tests. Other,
chi-squared tests, as well as extraction of correlation
regression coefficients, were performed when applicable.
Results
Characterization and Electrophysiological
Analyses of Atrial Cardiomyocyte-Specific
Mkk4-Deficient Mice
To study the functional importance of Mkk4 in the atria, we
developed atrial cardiomyocyte-specific Mkk4-deficient mice
by crossing mice carrying an Nppa promoter-driven Cre
transgene16 with mice with floxed Mkk4 alleles (Mkk4F/F).
Figure 1A and 1B summarizes the strategy and procedures for
developing the mouse model with atrial tissue-specific Mkk4
deletion (Mkk4ACKO). Mkk4ACKO mice that were born showed
the expected Mendelian ratios developing to term and
appeared normal. Immunoblot analysis of tissue lysates from
adult mice demonstrated an efficient reduction of Mkk4
expression in both left and right atrial (Figure 1C, top panel),
but not ventricular, tissue of Mkk4ACKO mice, compared to
corresponding Mkk4F/F controls (Figure 1C). Comparisons of
control Mkk4F/F with Mkk4ACKO samples confirmed that Mkk4
deletion did not result in compensatory changes in expression
of other MAPK components, including JNK, p38, or ERK1/2
(Figure 1D). Mkk4ACKO mice are therefore atrial specific and
suitable for studying functional roles of Mkk4 in the atrium. To
determine whether loss of Mkk4 affects activation of JNK or
p38, atrial tissues from two groups were collected 30 minutes
after Ang II treatment (8 mg/kg). Immunoblot analysis
showed that JNK activity increased in controls 30 minutes
after treatment, whereas mutant atria barely showed any
detectable activation (Figure 1E). In contrast, p38 activation
in both groups escalated to similar levels at 30 minutes
(Figure 1E). Hence, loss of Mkk4 specifically blunted atrial
activation of JNK, but not p38, activity.
Effects of Mkk4 deficiency on atrial electrophysiological
properties were then studied through comparisons between
Mkk4F/F and Mkk4ACKO mice. Because incidence of atrial
arrhythmia increases with age, ECG properties were examined
at regular intervals between 3 and 12 months of age. Under
baseline conditions, there were no significant differences in
heart rate, P wave duration, PR, QRS, or QT intervals in
surface ECGs between Mkk4ACKO and Mkk4F/F mice in all age
groups (Table 2). However, P wave amplitude became signif-
icantly reduced in Mkk4ACKO, relative to that of age-matched
Mkk4F/F mice, between 5 and 6 to 12 months of age
(Figure 1F), suggesting altered atrial electrical activity in
Mkk4ACKO mice. Furthermore, by age 5 to 6 months, the
occasionalMkk4ACKO (3 of 12) mouse, but none of theMkk4F/F
mice (0 of 11) showed spontaneous episodes of atrial tachy-
cardia or polymorphic atrial ectopic beats (Figure 2A).
The presence or otherwise, as well as the frequency, of
arrhythmic tendency in both Mkk4F/F and Mkk4ACKO in atria in
isolated Langendorff-perfused hearts from mice between 3
and 12 months of age were next compared during PES, in
which extrasystolic S2 stimuli followed successive trains of
eight pacing S1 stimuli delivered at 8 Hz at S1S2 intervals
progressively decremented by 1 ms with each successive
pacing cycle. Protocols were terminated when hearts either
became refractory or showed arrhythmia. Mkk4ACKO hearts
showed higher atrial arrhythmic incidences than the corre-
sponding control Mkk4F/F. At 3 months, 3 of 9 (33%)
Mkk4ACKO hearts displayed single or multiple episodes of
atrial tachycardia (AT) or nonsustained AF, whereas only 1 of
10 (10%) of Mkk4F/F showed a short AT (Table 3). Both
Mkk4F/F and Mkk4ACKO hearts showed increased atrial
arrhythmic susceptibility with age (Figure 2B), but to signif-
icantly greater extents in Mkk4ACKO hearts. At 12 months, all
(10 of 10) Mkk4ACKO, but only 3 of 9 (33%) Mkk4F/F, hearts
exhibited multiple episodes of nonsustained or sustained AT/
AF. Applications of Fisher’s exact test to such incidences
stratified successively by age and genotype indicated no
difference in arrhythmic incidences between Mkk4ACKO (n=9)
and Mkk4F/F (n=10) at 3 months, but significantly increased
arrhythmic incidences in Mkk4ACKO (n=9), but not Mkk4F/F
(n=10), at 12 months. Yet, all age groups of Mkk4ACKO and
Mkk4F/F mice showed statistically similar monophasic action
potential (MAP) durations (MAPD90) and atrial effective
refractory periods (AERP), whether in their left or right atria
(Table 3).
Epicardial multielectrode array (MEA) mapping of both left
and right atrial conduction properties were performed during
either sinus rhythm or PES, in isolated Langendorff-perfused
hearts. Figure 3A exemplifies activation maps through five
successive cardiac cycles from young (a and b) and old (c and
d), Mkk4F/F (a and c), and Mkk4ACKO hearts (b and d). Most
activation maps from Mkk4F/F hearts showed a sequential
activation pattern, beginning with a localized activation of one
region of the matrix followed by its successive spread to the
remaining area from which recordings were made. This
suggests an orderly spread of excitation within the plane of
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Figure 1. Generation ofMkk4ACKO mice and their electrophysiological characterization.
A and B, Schematic diagram illustrating the use of theCre-LoxP system in generating atrial-
specific deletion of Mkk4. C, Immunoblot analysis of Mkk4 expression from atrial and
ventricular extracts shows efficient deletion ofMkk4 fromatrial tissue inMkk4ACKO, but not
control,Mkk4F/F, mice. D, Deletion ofMkk4 does not lead to compensatory changes in the
MAPK proteins, JNK, p38, or ERK1/2. Tubulin illustrates equal loading. E, Ang II–induced
activation of JNK or p38 was examined by immunoblot analysis, indicating that the
deficiency of Mkk4 exclusively blocked JNK activation in atria. Immunoblot signals were
quantified using ImageJ software (National Institutes of Health, Bethesda, MD) and the
ratios of p-JNK to total JNK expression, and p-p38 to total p38 expression were calculated
and presented asmeansSEMs in the bar graphs (n=5 or 6 per group). Following Shapiro-
Wilk tests for normality, datawere compared using the paired Student t test, with a value of
P<0.05 vs. corresponding vehicle group considered to indicate statistical significance. F,
Comparison of P wave amplitudes between young and old Mkk4F/F and Mkk4ACKO. ECG
recordingsweremadeover5 minutes fromeachmouse. ECG traces froma1-minute record
showing a stable baseline were obtained from within this recording period. Results were
averaged over such ECG traces from 10 independent mice for each group. The mean and
SEM from thesewas then obtained. Data are presented asmeansSEMs (n=10 per group).
Ang II indicates angiotensin-II; CRE, CRE Recombinase; ERK, extracellular signal-regulated
kinase; JNK, c-Jun N-terminal kinase; MAPK, mitogen-activated protein kinase; Mkk4ACKO,
atrial cardiomyocyte specific mitogen-activated protein kinase kinase 4 knockout mice;
Mkk4F/F, Mkk4 flox/flox; NPPA, natriuretic peptide precursor A.
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the epicardium (a and c). However, the old Mkk4ACKO hearts
often showed a more disordered excitation sequence.
It was also possible to determine conduction velocities
within the right and left atria by using MEA recordings to
follow the pattern of spread from stimuli delivered through a
point in the center of, rather than adjoining, the array and
color coding the delays in arrival times as the resulting AP
spreads from the site of stimulation. The resulting velocities
were comparable in young (3-month) Mkk4F/F and Mkk4ACKO
hearts (Figure 3Ba, b). However, old Mkk4ACKO atria showed
slower conduction than old Mkk4F/F hearts. The isochronal
maps thus illustrated a pattern consistent with a slower
conduction in both left and right Mkk4ACKO than in Mkk4F/F
atria from 12-month-old hearts (Figure 3Ba, b). Mkk4 deletion
thus both alters conduction properties and increases atrial
arrhythmic susceptibility, particularly in old Mkk4ACKO mice.
Mkk4 Deficiency Leads to Increased Fibrosis and
Altered TGF-b1 Signaling in the Atrium With Age
Three series of experiments then explored the structural and
molecular basis of the slowed conduction and increased
arrhythmogenecity in aging Mkk4ACKO atria. First, levels of
fibrosis were examined by picrosirius red staining of histo-
logical sections from young (3- to 4-month), and old (12-
month) Mkk4F/F and Mkk4ACKO atrial tissue. Mkk4F/F and
Mkk4ACKO atria showed comparable levels of fibrotic tissue at
3 months (1.70.4% Mkk4F/F vs. 1.80.3% Mkk4ACKO;
Figure 4A, B). However, aging increased fibrosis in both
Mkk4F/F and Mkk4ACKO mice, with significantly greater effects
in Mkk4ACKO (6.10.4% at 12 months) than Mkk4F/F mice
(2.80.2% at 12 months).
Second, RNA was isolated from left atrial tissue from 3-
and 12-month-old Mkk4F/F and Mkk4ACKO mice for real-time
PCR analysis of gene expression of profibrotic signaling
components. Of these, the TGF-b1 pathway is one of the
major known profibrotic pathways; JNK is known to repress
TGF-b1 transcription.
7 Mkk4ACKO atrial tissue showed signifi-
cantly greater TGF-b1 mRNA expression, compared to Mkk4
F/F
controls, in 12-, but not 3-month-old, mice (Figure 4C). These
positive findings concerning TGF-b1 mRNA expression in aged
Mkk4F/F and Mkk4ACKO mice was complemented by similarly
positive differences in TGF-b1 protein expression (Figure S1).
It also showed significantly upregulated levels of both TGF-b
receptor I and II, compared to Mkk4F/F, at 3 months of age,
but these expression levels were equal by 12 months
(Figure 4D, E). These findings are consistent with deletion
of atrial Mkk4 increasing expression of TGF-b signaling
components, thereby providing a potential key mechanism
for increased atrial tissue fibrosis in 12-month-old Mkk4ACKO,
although consistent with an initially increased TGF-b receptor
expression followed by its downregulation by a subsequently
increased TGF-b expression.
A further important mechanism regulating fibrosis arises
from activity of matrix metalloproteinases (MMPs) and their
tissue inhibitors, tissue inhibitors of metalloproteinases
Table 2. Role of Mkk4 in Atrial Function in Aging: In Vivo ECGs
3 months 12 months
Mkk4F/F (n=6) Mkk4ACKO (n=6) Mkk4F/F (n=4) Mkk4ACKO (n=6)
RR interval, ms 131.874.99 134.324.57 146.015.36 142.593.89
Heart rate, bpm 460.8517.30 452.1216.03 416.0015.45 424.5512.66
PR interval, ms 34.951.79 32.351.31 39.631.76 37.991.99†
P duration, ms 15.811.33 14.882.30 12.630.57† 12.131.07
QRS interval, ms 9.000.47 9.540.37 9.250.34 9.130.39
QT interval, ms 15.130.48 14.840.41 20.962.37 18.572.05
QTc, ms 41.321.36 40.181.16 54.956.21 49.165.00
JT interval, ms 5.930.36 5.590.26 11.716.21 9.571.78
Q amplitude, mV 0.140.04 0.130.03 0.030.01† 0.050.02†
R amplitude, mV 0.860.16 0.970.11 0.870.10 0.950.08
S amplitude, mV 0.710.08 0.590.10 0.340.10† 0.190.07*†
ST height, mV 0.0070.013 0.0070.02 0.070.03† 0.040.02†
T amplitude, mV 0.200.05 0.200.04 0.160.03 0.160.03
Surface, in vivo ECGs in Mkk4F/F and Mkk4ACKO mice at 3 and 12 months of age reveal comparable ECG parameters. Following a Shapiro-Wilk test for normality, data were compared using
paired Student t tests or two-way ANOVA followed by post-hoc multiple comparison tests, where appropriate, assuming P<0.05 indicating statistically significance. Mkk4ACKO indicates
atrial cardiomyocyte specific mitogen-activated protein kinase kinase 4 knockout mice; Mkk4F/F, Mkk4 flox/flox.
*P<0.05, compared to Mkk4F/F at the same age group.
†P<0.05, compared to 3 month old at the same genotype group.
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(TIMPs). The JNK pathway has been reported to regulate
expression of many MMPs through activator protein 1 (AP1)
transcriptional activity.25 Real-time PCR analysis of two of the
major cardiac MMPs, MMP2 and MMP9, revealed significant
changes with age only in Mkk4ACKO tissue. However, whereas
MMP2 expression was decreased, MMP9 expression was
significantly increased at 12 months (Figure 4F, G). Neverthe-
less, of the major cardiac TIMPs,Mkk4F/F andMkk4ACKO tissue
showed similar TIMP2 expression levels at 3 months and both
were increased at 12 months, but with significantly higher
levels in theMkk4ACKO than theMkk4F/F. Thus, aging andMkk4
deletion appear to exert additive effects on TIMP2 expression
(Figure 4H).
Third, we examined expression of other candidate proteins
in atrial tissue from both young and old Mkk4ACKO and Mkk4F/F
mice that could contribute to slow conduction and atrial
arrhythmogenesis at either mRNA or protein levels. These
included the Na+ channel protein, Nav1.5, the calcium
handling proteins, ryanodine receptor 2 (RyR2), Na+/Ca2+
exchanger (NCX), and inositol 1,4,5-trisphosphate receptor
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Figure 2. In vivo and ex vivo electrophysiological characterizations. A, Representative ECG recordings
showing normal rhythm in a Mkk4F/F mouse (a) and polymorphic atrial ectopic beats and spontaneous atrial
tachycardic episodes recorded from Mkk4ACKO mice (b and c). B, Representative MAP traces recorded from
ex vivo hearts subjected to the PES S1S2 protocol recorded from atrial epicardium in Mkk4F/F (a) and
Mkk4ACKO (b and c) hearts. Atrial arrhythmias (AT and AF) were frequently observed in Mkk4ACKO after PES.
Bar graph shows summary of the occurrence of atrial arrhythmic events in Mkk4F/F and Mkk4ACKO hearts
(young Mkk4F/F, n=10; young Mkk4ACKO, n=9; old Mkk4F/F, n=10; old Mkk4ACKO, n=9). AF indicates atrial
fibrillation; AT, atrial tachycardial MAP, mitogen-activated protein; Mkk4ACKO, atrial cardiomyocyte specific
mitogen-activated protein kinase kinase 4 knockout mice; Mkk4F/F, Mkk4 flox/flox; PES, programmed
electrical stimulation.
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(IP3R), the transient receptor potential (TRP) channel proteins,
TRPC1, TRPC3, and TRPC6, and the gap junction proteins,
Cx40 and Cx43 (Figures 5 through 7). There were no
significant differences in mRNA or protein expression
between Mkk4F/F and Mkk4ACKO mice.
Computer Simulations
The results above suggested that fibrotic processes might
lead to the electrophysiological phenotypes and atrial
arrhythmogenesis in Mkk4ACKO mice. Our computer modeling
studies then explored biophysical mechanisms through which
such increases in fibroblast population might alter atrial
electrical excitation and its propagation to result in these
proarrhythmic effects. First, we investigated effects of an
electrical coupling between fibroblasts and cardiomyocytes
(Figure 8A) on atrial APs at the single-cell level. Coupling to
fibroblasts decreased the overshoots and maximal upstroke
velocities of atrial APs, prolonged their APDs, and made
resting potentials more positive (Figure 8B) to extents that
increased with the number of coupled fibroblasts. Figure 8B
(inset) exemplifies this for the maximal AP upstroke velocity.
A coupling of more than 10 fibroblasts resulted in the
membrane potential of the atrial cell model failing to attain
the activation threshold of INa to generate an AP. These atrial
AP modulations reflected the dual action of coupled fibro-
blasts as both a passive load and a driver to a cardiomyocyte
over the AP time course. Thus, the more depolarized fibroblast
resting potential would drive in a depolarizing current into the
coupled cardiomyocyte when this was at its resting potential
and the late repolarization phase of its AP. This would elevate
the cardiomyocyte resting potential and prolong its APD.
However, it would drive a repolarizing current during the AP
upstroke and phase 1 and 2 repolarization. This would
decrease the overshoot and the maximal upstroke velocity of
the atrial AP (Figure 8B, bottom panel).
Use of a 2D model demonstrated that fibroblast-cardio-
myocyte couplings modified the CV of atrial excitation waves
to extents that varied with fibroblast density (Figure 8C),
thereby replicating observed alterations in control and aged
Mkk4ACKO or Mkk4F/F. Measured CVs decreased monoton-
ically with increased fibroblast density. The simulations that
incorporated Mkk4ACKO and aging effects adopted diffusion
coefficients chosen to reproduce experimentally measured
CVs in the respective young and old groups of Mkk4ACKO and
Mkk4F/F. This then yielded computed CVs with a greater
negative dependence on fibroblast density in the old than
the young group. Finally, the presence of fibroblast-cardio-
myocyte coupling disturbed the wavefronts of atrial excita-
tion waves. Figure 8D exemplifies results from a standard
S1 to S2 stimulation protocol26 (basic cycle length=150 ms)
applied at the left edge of the 2D model containing randomly
distributed fibroblast populations, resulting in a range from
one to five fibroblasts coupled to any given cardiomyocyte.
The snapshots of the excitation waves evoked by the S2
stimulus, applied at a S1S2 coupling interval of 60 ms,
demonstrated that the wavefront of atrial excitation wave
became broken. This led to formation of re-entrant excitation
waves (Figure 8D).
TGF-b Signaling in Mkk4-Inactivated
Cardiomyocytes and Cardiomyocyte-Fibroblast
Crosstalk
Experiments on cultured NRCMs infected with either wild-type
(WT) Ad-GFP or Ad-dnMKK4 directly demonstrated that MKK4
inactivation altered profibrotic signaling whether in the
absence or presence of Ang II stimulation.
First, as shown in Figure S2, the transcriptional levels of
TGF-b1, collagen, type 1, alpha 2 (Col1a2), MMP2, and TIMP
were compared in the NRCMs infected with or without Ad-GFP
followed by 24 hours of stimulation of Ang II. There was no
difference in these transcripts between these two groups,
indicating that Ad-GFP does not affect the transcriptional
levels of TGF-b1, Col1a2, MMP2, and TIMP in NRCMs under
the Ang II stress condition. MKK4-inactivated NRCMs, but not
WT NRCMs showed increased TGF-b1 mRNA expression
(Figure 9A) under basal conditions. In contrast, Col1a1 and
MMP2 expression was not significantly different between the
two groups. After 24 hours of treatment with Ang II
(500 nmol/L), MKK4-deficient NRCMs showed significantly
Table 3. Ex Vivo Measurements
3 months old 12 months old
Mkk4F/F
(n=10)
Mkk4ACKO
(n=9)
Mkk4F/F
(n=9)
Mkk4ACKO
(n=10)
HR, bpm 41518 49524*† 38228† 37222†
LA APD90,
ms
52.75.6 59.39.9 75.510.5 84.512.6
LA ERP, ms 49.212.8 38.27.9 51.511.5 45.87.4
RA APD90,
ms
56.04.5 51.58.3 66.07.7† 77.149.4†
RA ERP, ms 41.933.6 40.35.2 49.784.5 48.286.5
% arrhythmia 10% 33% 33% 100%
Ex vivo parameters measured by monophasic action potential recordings, from left atria
(LA), right atria (RA), in young (3 month) and old (12 month), Mkk4F/F, and Mkk4ACKO
mice. Heart rate (HR), action potential duration 90 (APD90), and effective refractory
period (ERP) were calculated and arrhythmic events, including periods of atrial
tachycardia (AT) or atrial fibrillation (AF), were recorded. Following Shapiro-Wilk tests for
normality, data were compared using the paired Student t tests or two-way ANOVA
followed by post-hoc multiple comparison tests, where appropriate, assuming P<0.05
indicating statistical significance. Mkk4ACKO indicates atrial cardiomyocyte specific
mitogen-activated protein kinase kinase 4 knockout mice; Mkk4F/F, Mkk4 flox/flox.
*P<0.05, compared to Mkk4F/F at the same age group.
†P<0.05, compared to 3 month old at the same genotype group.
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higher levels of TGF-b1 and TIMP transcripts than did the
corresponding WT NRCMs. MKK4 deficiency thus enhances
Ang II–induced upregulation of TGF-b1 signaling and TIMP
activity (Figure 9A). This effect likely involves alterations in
the crosstalk between cardiomyocytes and fibroblasts. This
was suggested in experiments in which WT NRCMs and
MKK4-inactivated NRCMs were first treated with Ang II
(500 nmol/L) for 24 hours. NRCM-conditioned medium was
then transferred to plated NRCFs. These were then further
incubated for 24 hours before RNA was extracted. Cultured
NRCFs that received conditioned medium from MKK4-defi-
cient NRCMs yielded significantly higher Col1a1 mRNA levels
than did NRCFs that received conditioned medium from WT
NRCMs (Figure 9B). Thus, MKK4 inactivation in NRCMs
modified their profibrotic paracrine signaling to NRCFs, likely,
in part, by increasing transcriptional activity of Col1a1 in
NRCFs. The importance of TGF-b1 activity in MKK4-mediated
regulation of fibrosis was demonstrated in experiments in
which cell culture media from NRCMs, treated as described
above, was transferred to a TGF-b reporter cell line (TMLC
cells). Their TGF-b1 activity was then measured using
luciferase reporter assays. Media from NRCM cells infected
with dominant negative MKK4, resulted in a significant
increase in TGF-b1 activity in the TMLC cell line (Figure 9C).
Thus, MKK4 may regulate the amount of active TGF-b1
produced by cardiomyocytes and can directly affect TGF-b1
transcriptional activity in colocalized cells. Together, these
findings suggest mechanisms through which deletion of MKK4
in atrial cardiomyocytes could lead to increased profibrotic
signaling in fibroblasts.
A
3 months
0 1 2 3 4 65 7 ms
MKK4ACKO
MKK4F/F
3 months
MKK4ACKO
MKK4F/F
12 months
12 months
B
RA                                   LA
0.2mm
MKK4ACKO
MKK4F/F
ms
1 2 3 4 5 6
1 2 3 4 5 6
3 12
RA
n.s
MKK4ACKO
MKK4F/F
0
0.2
0.4
0.6
M
ea
n 
co
nd
uc
tio
n 
ve
lo
ci
ty
 
(m
m
/m
s)
 
P<0.05
n.s P<0.05
a b
beat 1 beat 2 beat 4beat 3 beat 5
months3
LA
12
a
b
c
d
Figure 3. Epicardial electrical mapping with a multielectrode array (MEA). A, Representative activation
maps of five successive cardiac cycles under sinus rhythm in Mkk4F/F (a and c) and Mkk4ACKO hearts (b and
d) grouped by age in 3- (a and b) and 12 month-old hearts (c and d). B, Representative pacing-induced
activation maps generated by pacing in the center of array on the epicardium of the right (RA) and left atria
(LA) of Mkk4F/F and Mkk4ACKO mice (a). Velocities in the left (LA) and right atrium (RA) of young and old
Mkk4F/F and Mkk4ACKO mice are shown as bar graphs (meansSEMs). Following Shapiro-Wilk tests for
normality, data were compared between groups using the paired Student t test, with a value of P<0.05
considered to indicate statistical significance (b). (n=5 per group for both young and old Mkk4F/F and
Mkk4ACKO). Mkk4ACKO indicates atrial cardiomyocyte specific mitogen-activated protein kinase kinase 4
knockout mice; Mkk4F/F, Mkk4 flox/flox.
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MKK4 Expression Is Reduced in Atrial Tissue in
Patients With AF
The translational significance of the results described above
was explored through assessment of expression levels at the
mRNA and/or protein levels of key MAPK components and
profibrotic signaling molecules in atrial tissues from age-
matched cardiac surgery patients in sinus rhythm (SR) and AF.
AF patients showed increased left atrial diastolic diameters
(LADD; Table 1), suggesting the dilated left atria characteristic
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Figure 4. Structural and molecular characterizations. A, Representative images of picrosirius red stained
tissue, with fibrotic areas stained dark red, taken at 409 magnification in Mkk4F/F and Mkk4ACKO mice at
ages of 3 (n=5) and 12 months (n=7). B, Quantification of the percentage area of fibrosis in young (left)
and old (right), Mkk4F/F (white), and Mkk4ACKO (black) mice by picrosirius red staining. C through H, Real-
time PCR analysis of TGF-b1 (C), TGF-b receptor 1 (TGF-b R1; D), TGF-b receptor 2 (TGF-b R2; E), MMP2 (F),
MMP9 (G), and TIMP2 mRNA expression (H), from young and old Mkk4F/F and Mkk4ACKO left atria. The
derived data are normalized to the housekeeping gene (HPRT) content, and the relative expression was
calculated using the 2DDCT method. A Shapiro-Wilk test was used to check whether data came from a
normal distribution before data analysis using two-way ANOVA followed by Bonferonni-corrected post-hoc t
tests, with a value of P<0.05 considered to indicate statistical significance. Data are presented as
meansSEMs (n=4 per group for both young and old Mkk4F/F and Mkk4ACKO). HPRT, hypoxanthine
phosphoribosyltransferase; Mkk4ACKO indicates atrial cardiomyocyte specific mitogen-activated protein
kinase kinase 4 knockout mice; Mkk4F/F, Mkk4 flox/flox; MMP, matrix metalloproteinase; PCR, polymerase
chain reaction; TGF-b, transforming growth factor-b; TIMP, tissue inhibitors metalloproteinase.
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of impaired left ventricular function, a risk factor for AF.
Quantitative PCR (qPCR) analysis demonstrated significant
downregulation in MKK4, but not MKK7, P38, and JNK,
transcription in AF patients, relative to control patients in SR
(Figure 10A). Western blot analysis further confirmed
decreased MKK4 protein levels in AF patients (Figure 10B).
qPCR analysis of profibrotic gene expression revealed signif-
icant increases in levels of collagens, including Col1a1 and
Col3a1, upregulation of the profibrotic connective tissue
growth factor (CTGF) and downregulation of MMP2 in AF
patients, suggesting an increased profibrotic signaling in their
atria (Figure 10A). Finally, because AF is strongly associated
with aging, we further divided these patients into three age
groups (<65, 65 to 75, and >75 years old) to analyze the
correlation between MKK4 expression with aging. In both SR
and AF patients, MKK4 mRNA levels were significantly
decreased in those >75 years, compared to the younger
age groups (<65 and 65 to 75; Figure 10C).
Discussion
The principal outcome of this study is the demonstration that
Mkk4 acts as a negative regulator of atrial remodeling and
arrhythmogenesis with age, that it does so through a
mechanism associated with TGF-b1 signaling, and that the
latter is likely mediated through JNK-regulated signaling. A
corroborating clinical study reports that AF patients show
remarkably decreased MKK4 expression. Together, these
findings argue, for the first time, that MKK4 is functionally
important in the pathogenesis of human AF.
Mkk4 Signaling and Age-Related Atrial
Remodeling
Atrial fibrosis is a key substrate for the initiation and
maintenance of AF through its associated alterations in
tissue architecture, composition, and electrophysiological
function.27–29 The precise signaling mechanisms underlying
its development with age remain unclear. The present study
implicates Mkk4 in age-dependent atrial fibrosis and its
associated electrical remodeling. Our experimental electro-
physiological studies demonstrate that Langendorff-perfused
Mkk4ACKO, but not Mkk4F/F, hearts became more susceptible
to atrial arrhythmias with age. Aged Mkk4ACKO atria also
showed reduced P wave amplitudes, dispersed and hetero-
geneous activation patterns suggesting spatial nonuniformi-
ties in propagation, slower atrial tissue conduction, and
increased histological evidence for interstitial fibrosis. In
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Figure 5. Transcriptional expression of Ca2+ handling proteins RyR2, SERCA2a, and NCX1, the TRPC channels, TRPC1, 3, and 6, the IP3
receptors, IP3R1 and IP3R2, and major connexins (Cx) Cx40 and Cx43. Total RNA was extracted from atria of young (3-month) and old (12-
month) Mkk4F/F and Mkk4ACKO mice. This was followed by cDNA synthesis and qPCR analysis. The derived data are normalized to the
housekeeping gene (HPRT) content, and the relative expression was calculated using the 2DDCT method. Following a Shapiro-Wilk test for
normality, data were analyzed using the paired Student t test or two-way ANOVA followed by Bonferroni-corrected post-hoc multiple comparison
tests, where appropriate, with a value of P<0.05 considered to indicate statistical significance. Y: young (3 month old); O: old (12 month old);
ns: not significant; results are presented as meansSEM (n=4 per group for both young and old Mkk4F/F and Mkk4ACKO). Mkk4ACKO indicates
atrial cardiomyocyte-specific mitogen-activated protein kinase kinase 4 knockout mice; Mkk4F/F, Mkk4 flox/flox; NCX, sodium calcium
exchanger; PCR, polymerase chain reaction; RyR, Ryanodine receptor; SERCA, sarcoendoplasmic reticulum Ca2+ATPase; TRPC, transient
receptor potential cation channel.
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contrast, ex vivo Mkk4ACKO and Mkk4F/F hearts showed
similar APD90 and ERP values, as well as indistinguishable
connexin expression levels and distribution through all age
groups. Such findings suggest an increased arrhythmogene-
city attributable to fibrotic events, as opposed to altered
cellular electrophysiology. Such changes are known to occur
in both animal models of, and patients with, AF, the latter
including the lone AF observed in the absence of other
cardiovascular disease.29–31
Our computational studies correspondingly demonstrated
that atrial tissue containing randomly distributed fibroblast
populations, modeled in two dimensions, became more
heterogeneous. Fibroblast-cardiomyocyte coupling then slo-
wed down atrial CV and prolonged APD more in the localized
regions with greater fibroblast populations. Premature S2
stimuli at short coupling time intervals did not permit full
recovery of such localized regions with high fibroblast
densities from their previous excitation because of their long
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Figure 6. Expression of Nav1.5, connexin 40 (Cx40), and connexin 43 (Cx43) in the atria from young and
old Mkk4F/F and Mkk4ACKO mice. A, Immunoblot analysis on two batches of samples. Tubulin expression is
the protein loading control. B, Immunoblot signals were quantified using ImageJ software (National
Institutes of Health) and the ratios of Nav1.5/tubulin, connexin 40/tubulin, and connexin 43/tubulin are
represented by the bar graphs. Following a Shapiro-Wilk test confirming normality, data were analyzed using
the paired Student t test, with a value of P<0.05 considered to indicate statistical significance. Data are
expressed as meansSEMs (n=4 per group for both young and old Mkk4F/F and Mkk4ACKO). Mkk4ACKO
indicates atrial cardiomyocyte-specific mitogen-activated protein kinase kinase 4 knockout mice; Mkk4F/F,
Mkk4 flox/flox.
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refractory periods. This resulted in formation of regions of
functional conduction block fragmenting the atrial excitation
wavefronts and leading to formation of re-entrant excitation
waves. Thus, increases in fibroblast density or alterations in
fibroblast-cardiomyocyte coupling alter atrial electrophysio-
logical properties and result in an arrhythmogenic substrate
offering sources for local micro re-entry that might form the
trigger for the AT/AF observed in Mkk4ACKO hearts and also
account for the widespread, generalized process of junctional
remodeling that has been observed in patients with AF.29–32
Mkk4 might then function in maintaining normal atrial
electrical function during aging through limiting such struc-
tural remodeling through regulation of atrial fibrosis.
Mechanistic Links Between Mkk4 and
Transduction by TGF-b1 Signaling
The TGF-b-signaling pathway constitutes one of the central
regulators for cardiac fibrotic alterations, which have been
associated with various cardiac disease conditions that
include AF.28,29 Cardiac overexpression of constitutively
active TGF-b1 is known to cause selective atrial fibrosis,
conduction heterogeneity, and AF susceptibility.33 Mkk4
deficiency led to an increase in expression of TGF-b-signaling
components, providing a possible mechanism by which atrial
fibrosis may be exacerbated with age in Mkk4ACKO mice.
How does MKK4 deletion upregulate the TGF-b-signaling
pathway? First, MKK4 is a well-recognized upstream kinase in
the JNK-signaling pathway and regulates diverse physiological
processes through activating JNKs.34 Recent studies, includ-
ing ours, have suggested that MKK4 in the heart is an
important regulator of activation of the JNK pathway.14,15,17
Our findings suggest that MKK4 acts as a negative regulator
of TGF-b1 signaling through JNK activity. This is consistent
with recent findings that JNK-deficient fibroblasts isolated
from Jnk1/Jnk2/ embryos containing the embryonically
lethal Jnk1/Jnk2/ genotype constitutively express TGF-
b1 (Ventura et al.
7). These studies had demonstrated that
JNK/c-Jun signaling represses Tgf-b1 gene expression, in an
important crosstalk between the TGF-b1- and JNK-signaling
pathways.7 Our present study further demonstrates that TGF-
b1 mRNA as well as both TGF-b receptors I and II were
significantly upregulated in Mkk4ACKO, relative to Mkk4F/F
atria. Our results further demonstrated alterations in MMPs
and their inhibitors, TIMPs25 in Mkk4ACKO atria, in the form of
additive effects of aging and Mkk4 deletion on TIMP2
expression. However, these findings were less clear cut, in
that whereas MMP2 expression was decreased, MMP9
expression was significantly increased at 12 months. These
findings were reinforced by our further in vitro comparative
studies in Mkk4-inactivated and WT NRCMs.
Effects of Cardiomyocyte-Fibroblast Crosstalk on
Profibrotic Signaling
Our studies in NRCMs and NRCFs revealed that crosstalk
between two cell types affected profibrotic signaling. Cardio-
myocytes account for 45% of the atrial myocardium by
volume, whereas nonmyocytic cells are thought to compose
70% of cardiac cells by number.30 There is a complex
3 months 12 monthsCx43
Cx40 3 months 12 months
MKK4F/F
MKK4ACKO
MKK4F/F
MKK4ACKO
Scale bar: 20μm 
Figure 7. Immunohistochemical staining of connexin 40 (Cx40)
and connexin 43 (Cx43) in the atria shows similar distribution
between Mkk4F/F and Mkk4ACKO mice in young (3 months) and old
age (12 months). Scale bar, 20 lm (n=4 per group for both young
and old Mkk4F/F and Mkk4ACKO). Mkk4ACKO indicates atrial cardio-
myocyte-specific mitogen-activated protein kinase kinase 4 knock-
out mice; Mkk4F/F, Mkk4 flox/flox.
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interplay among these two cell types, the more numerous of
which are cardiac fibroblasts. The fibroblast was traditionally
thought to be a passive bystander in the myocardium, but is
now recognized to participate actively in shaping and
responding to the cardiac milieu.30 Both fibroblasts and
cardiomyocytes are important profibrotic mediators.30 Car-
diac overexpression of constitutively active TGF-b1 causes
selective atrial fibrosis, conduction heterogeneity, and sus-
ceptibility to AF.33 TGF-b1 functions as a downstream
mediator of Ang II through both para- and autocrine mech-
anisms. It acts primarily through the SMAD pathway to
stimulate fibroblast activation and collagen production.
Knockdown of MKK4 in cultured cardiomyocytes increased
their sensitivity to Ang II stimulation on TGF-b1-signaling
activation; such a change, in turn, enhanced paracrine
expression of profibrotic molecules in cultured cardiac fibro-
blasts. Ang II has been shown to induce extracellular matrix
protein synthesis and secretion in cardiac fibroblasts.35
Cardiomyocytes are not likely to directly synthesize collagen,
but instead interact with neighboring fibroblasts to stimulate
collagen synthesis and secretion, thereby resulting in the
structural remodeling that we observed in Mkk4ACKO mice.
Author Summary Figure 11 illustrates such a prediction.
MKK4 Dysregulation in Atrial Tissue in Patients
With AF
A key question concerns the applicability of the results obtained
from our mouse models and in vitro studies to human
conditions. Our study on human atrial tissue demonstrated
Figure 8. Computer simulation of the effects of fibroblast-cardiomyocyte coupling. A, Schematic plot of a
2D tissue model with random fibroblast insertion. The diamond shape represents the gap junction between
myocytes; the round shape represents the gap junction between fibroblasts and cardiomyocytes. B, Effects
of fibroblast insertion on the membrane potential for the coupled myocyte. The inset shows the schematic
plot of interconnected coupling. I, no fibroblast coupled; II, three fibroblasts coupling; III, four fibroblasts
coupling If fibroblasts are present, gap junctions between myocytes are replaced by a fibroblast-myocyte
gap junction. C, Computer simulation of the effects of fibroblast-cardiomyocyte coupling on conduction
velocity (CV). D, Voltage snapshots showing re-entry induced by the premature beat. The first plot shows
the pattern of random fibroblast distribution, where the red spot represents fibroblast-cardiomyocyte
coupling.
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that MKK4, but not MKK7, p38, and JNK, was significantly
downregulated in AF patients at both the mRNA and protein
levels. A significant increase in collagens, including Col1a1 and
Col3a1, was accompanied by upregulation of CTGF and
downregulation of MMP2 in AF patients, compared to control
patients in SR, which suggests a correlation between AF and
increased profibrotic signaling pathways in the atrium in these
patients.
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Figure 9. TGF-b signaling in NRCMs and NRCFs. A, NRCMs were infected with either adenovirus encoding
GFP (Ad-GFP, as control) or dominant negative MKK4 adenovirus (Ad-d/nMKK4). Transcriptional levels of
TGF-b1, Colalpha1, MMP2, and TIMP2 in these NRCMs were examined by qPCR in response to Ang II
stimulation at 500 nmol/L for 24 hours. B, Conditional media from NRCMs treated by Ang II were
transferred to NRCFs for 24 hours. Transcriptional levels of TGF-b1, Colalpha1, MMP2, and TIMP2 in NRCFs
were measured by qPCR. C, Conditional media from NRCMs treated by Ang II was transferred to a TGF-b
reporter cell line (TMLC cells) in which the TGF-b activity was indicated by a luciferase reporter. The TGF-b1
activity in the media was then measured using luciferase reporter assays. Data were derived from three
independent batches of cells obtained on different dates studied in triplicate and presented as
meansSEMs. Following a Shapiro-Wilk test to confirm normality, data were analyzed using paired Student
t tests or two-way ANOVA followed by post-hoc multiple comparison tests, where appropriate, with a value
of P<0.05 considered to be statistically significant (n=3 per group). Ang II indicates angiotensin II; GFP,
green fluorescent protein; MKK4, mitogen-activated protein kinase kinase 4; MMP, matrix metalloprotein-
ase; NRCMs, neonatal rat cardiomyocytes; NRCFs, neonatal rat cardiac fibroblasts; PCR, polymerase chain
reaction; TGF, transforming growth factor; TIMP, tissue inhibitors metalloproteinase.
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Conclusions and Limitations of the Study
In summary, we suggest, for the first time, a critical role for
MKK4 in age-related atrial structural remodeling associated
with AF. MKK4 is therefore a potential novel therapeutic
target for management of, and a potential novel biomarker for
susceptibility to, AF. We also report clear-cut evidence
implicating MKK4 as a negative regulator for profibrotic
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Figure 10. MKK4 expression is reduced in atrial fibrillation patients. A, qPCR analysis shows
transcriptional levels of MAPK signaling components: MKK4, MKK7, p38, and JNK and fibrotic genes:
TGF-b1, TGF-b2, TGF-bR1, TGF-bR2, CTGF, Col1a1, Col1a2, Col3a1, MMP2, and TIMP2 in the atria from
sinus rhythm (SR) and atrial fibrillation (AF) patients. B, Immunoblot analysis demonstrates the protein level
of MKK4 in the atria of SR and AF patients. GAPDH expression is the protein loading control. Immunoblot
signals were quantified using ImageJ software (National Institutes of Health), and the ratios of MKK4/
GAPDH are represented by the bar graphs. Following a Shapiro-Wilk test to confirm normality, data were
compared between groups using paired Student t tests, with a value of P<0.05 taken to indicate statistical
significance. Data are expressed as meansSEMs. C, Transcription level of MKK4 in the atria from SR
(n=15) and AF (n=15) patients in different age groups (<65, 65 to 75, and >65). Following Shapiro-Wilk
normality tests, data were analyzed using paired Student t tests or two-way ANOVA followed by post-hoc
multiple comparison tests, where appropriate, with a value of P<0.05 considered statistically significant.
Data are presented as meansSEM. CTGF indicates connective tissue growth factor; GADPH,
glyceraldehyde 3-phosphate dehydrogenase; JNK, c-Jun N-terminal kinase; MAPK, mitogen-activated
protein kinases; MKK4, mitogen-activated protein kinase kinase 4; MMP, matrix metalloproteinase; PCR,
polymerase chain reaction; TGF, transforming growth factor; TIMP, tissue inhibitors metalloproteinase.
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signaling through TGF-b1, likely through its regulation by JNK
activity, but provide less-clear-cut outcomes concerning roles
of profibrotic signaling pathways involving MMPs and their
tissue inhibitors (TIMPs), therefore justifying further study of
these (Figure 11). Further studies may also increase the
population from which human biopsy results are obtained and
extend our MEA and computational modeling studies to
evaluate further possible mechanisms by which increased
fibroblast populations alter atrial electrical excitation and its
propagation to produce arrhythmic effects. Finally, a broader
analysis would recognize that although atrial fibrosis may
contribute to AF, AF also occurs in the absence of fibrosis,
and this has implications for our understanding of the
development of this condition and the role of other predis-
posing risk variants.
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